Lindenwold Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$279K Buy
2,216
+56
+3% +$7.04K 0.14% 90
2025
Q1
$239K Buy
+2,160
New +$239K 0.13% 93